Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Isacoff

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
World Journal of Surgery|September 1, 1997
Chemotherapy for the treatment of patients with metastatic colorectal cancer: an overviewW H Isacoff, K Borud
Cancer Treatment Reports|April 1, 1984
Abnormal deoxyuridine suppression as a rapid predictor for antimetabolite chemosensitivity: correlation with in vitro tests of growth inhibitionJ B Block, R T Chlebowski, M F Dietrich, et al.
The American Surgeon|September 19, 2000
Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapyB D Beseth, R Bedford, W H Isacoff, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 3, 1998
Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamoleK E Todd, B Gloor, J S Lane, et al.
Cancer Treatment Reports|December 1, 1977
Pharmacokinetics of high-dose methotrexate with citrovorum factor rescueW H Isacoff, P F Morrison, J Aroesty, et al.
Medical and Pediatric Oncology|January 1, 1976
High dose methotrexate therapy of solid tumors: observations relating to clinical toxicityW H Isacoff, C M Townsend, F R Eiber, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 2, 2001
Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin)P Büchler, H A Reber, M C Büchler, et al.
Cancer Treatment Reports|September 1, 1978
Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescueW H Isacoff, F Eilber, H Tabbarah, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
World Journal of Surgery|September 1, 1997
Chemotherapy for the treatment of patients with metastatic colorectal cancer: an overviewW H Isacoff, K Borud
Cancer Treatment Reports|April 1, 1984
Abnormal deoxyuridine suppression as a rapid predictor for antimetabolite chemosensitivity: correlation with in vitro tests of growth inhibitionJ B Block, R T Chlebowski, M F Dietrich, et al.
The American Surgeon|September 19, 2000
Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapyB D Beseth, R Bedford, W H Isacoff, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 3, 1998
Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamoleK E Todd, B Gloor, J S Lane, et al.
Cancer Treatment Reports|December 1, 1977
Pharmacokinetics of high-dose methotrexate with citrovorum factor rescueW H Isacoff, P F Morrison, J Aroesty, et al.
Medical and Pediatric Oncology|January 1, 1976
High dose methotrexate therapy of solid tumors: observations relating to clinical toxicityW H Isacoff, C M Townsend, F R Eiber, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 2, 2001
Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin)P Büchler, H A Reber, M C Büchler, et al.
Cancer Treatment Reports|September 1, 1978
Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescueW H Isacoff, F Eilber, H Tabbarah, et al.
Pageof 1